Medical and Pharmaceutical Industry - Market Research Report

  Sternal Closure Systems Industry Overview The global sternal closure systems market size was estimated to be valued at USD 2.39 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 5.4% from 2022 to 2030. The expanding base of the geriatric population undergoing open-heart surgery through median sternotomy is considered to be one of the primary growth stimulants for the market. The median sternotomy procedure has remained the most popular technique for cardiac exposure to date, owing to easy and quick access to heart valves and vessels. Sternotomy and sternal closure occur prior to and post-cardiac surgery respectively. Moreover, rapid technological advancements, such as the use of biocompatible polymers including  PEEK , tritium, nitinol, pre-sternotomy plates, and the development of minimal invasive median sternotomy procedures, are expected to drive the market growth. A rise in the number of surgical procedures globally has driven demand for

  Biopharmaceuticals Contract Manufacturing Industry Overview The global biopharmaceuticals contract manufacturing market was valued at USD 17.0 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% during the forecast period. The success of the biopharmaceutical market can be majorly attributed to the contract manufacturers. Reduction in the overall investment required to bring a new drug product to market, providing access to expensive technologies, quick entry of products into the markets, and greater flexibility are some advantages offered by contract manufacturing organizations (CMOs), which have prompted the companies to outsource their biopharmaceutical manufacturing. Due to the disruptions from COVID-19, many companies have had to bring on new contract manufacturers or ingredient suppliers due to increasing demands. Furthermore, with a perpetual expansion of the biopharmaceutical industry, the companies are facing production issues, such a

  Colposcopy Industry Overview The global colposcopy market size was valued at USD 427.0 million in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030. Factors such as the rise in the prevalence of cervical cancer and the high demand for early diagnostic techniques are expected to boost market growth. According to Global Cancer Observatory, in 2020, about 604,127 new cases of cervical cancer were diagnosed globally and 341,831 deaths occurred in the same year due to the disease. Additionally, by 2025, the incidence of cervical cancer is expected to increase to 1,495,211. Colposcopy is a highly efficient technique for early diagnosis of lesions and selecting biopsy sites due to its high precision, adaptability, ease of use, and non-invasive approach. It further allows for a magnified evaluation of the cervix and lower genital tract for either dysplastic or malignant epithelial lesions. For decades, gynecological examinations were subj